| The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society | Atherosclerosis | 2015 | 420 |
| Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel | Archives of Medical Science | 2015 | 252 |
| Non-alcoholic fatty liver disease and dyslipidemia: An update | Metabolism: Clinical and Experimental | 2016 | 212 |
| Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? | Metabolism: Clinical and Experimental | 2006 | 208 |
| Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study | Current Medical Research and Opinion | 2006 | 191 |
| Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel | Nutrition Reviews | 2017 | 186 |
| Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation | Nutrition Reviews | 2017 | 183 |
| The Role of Nutraceuticals in Statin Intolerant Patients | Journal of the American College of Cardiology | 2018 | 157 |
| The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement | Metabolism: Clinical and Experimental | 2017 | 152 |
| The role of Toll-like receptors in renal diseases | Nature Reviews Nephrology | 2010 | 145 |
| Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | Journal of the American Heart Association | 2016 | 141 |
| Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials | Mayo Clinic Proceedings | 2015 | 139 |
| "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses | Current Vascular Pharmacology | 2011 | 138 |
| The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions | Current Medical Research and Opinion | 2005 | 138 |
| Lipid-modifying effects of nutraceuticals: An evidence-based approach | Nutrition | 2016 | 133 |
| Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients | International Journal of Cardiology | 2015 | 129 |
| Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies | BMC Medicine | 2015 | 126 |
| Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease | British Journal of Surgery | 2001 | 125 |
| Endocan: A novel inflammatory indicator in cardiovascular disease? | Atherosclerosis | 2015 | 123 |
| Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms | Atherosclerosis | 2016 | 117 |
| Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study | Nephrology Dialysis Transplantation | 2007 | 114 |
| The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study | Diabetes, Obesity and Metabolism | 2005 | 114 |
| Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics | Clinical Endocrinology | 1990 | 114 |
| Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort | Angiology | 2007 | 113 |
| Leptin, cardiovascular diseases and type 2 diabetes mellitus | Acta Pharmacologica Sinica | 2018 | 112 |
